74 related articles for article (PubMed ID: 1135891)
1. Urine excretion of nucleosides in Hodgkin's disease treated by combined chemotherapy.
Dienstbier Z; Buric L
Strahlentherapie; 1975 Feb; 149(2):208-11. PubMed ID: 1135891
[TBL] [Abstract][Full Text] [Related]
2. Deoxypyrimidineuria in the course of chemotherapy in M. Hodgkin.
Dientsbier Z; Buric L; Bechynĕ M; Kovaríková H; Foltýnová V; Mostecký H
Neoplasma; 1976; 23(6):645-65. PubMed ID: 1004661
[TBL] [Abstract][Full Text] [Related]
3. Individual changes of DNA catabolite excretion in the course of antitumor therapy of Hodgkin's disease.
Dienstbier Z; Blehová Z; Masopust J; Sámal M
Strahlentherapie; 1980 Apr; 156(4):240-3. PubMed ID: 7368228
[TBL] [Abstract][Full Text] [Related]
4. [Changes of serum amino acids during polychemotherapy in Hodgkin's disease].
Tilz GP; Stübchen-Kirchner H; Sailer S
Wien Med Wochenschr; 1974 Oct; 124(42-43):617-9. PubMed ID: 4439956
[No Abstract] [Full Text] [Related]
5. [Experience with combined drug therapy of Hodgkin's disease, using chlorambucil, vinblastine, procarbazine and prednisolone].
Berényi E; Dankó K; Szegedi G
Orv Hetil; 1980 Mar; 121(10):571-3. PubMed ID: 7366965
[No Abstract] [Full Text] [Related]
6. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
7. [Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
Aiba K; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Dohmyo M; Nagata T; Miyamoto H; Kobayashi T; Kuraishi Y
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1928-32. PubMed ID: 6897857
[TBL] [Abstract][Full Text] [Related]
8. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC
Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551
[No Abstract] [Full Text] [Related]
10. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD
Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
[TBL] [Abstract][Full Text] [Related]
11. Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease.
Raina V; Sharma A; Mohanti BK; Kumar R; Dawar R; Rath GK
Natl Med J India; 2003; 16(4):199-203. PubMed ID: 14606767
[TBL] [Abstract][Full Text] [Related]
12. [Initial results of hybrid chemotherapy of Hodgkin's disease using COPP/VBA].
Schneider T; Molnár Z; Szántó I; Fleischmann T
Orv Hetil; 1992 Oct; 133(43):2755-7. PubMed ID: 1383907
[TBL] [Abstract][Full Text] [Related]
13. [Use of prospidin in the combination chemotherapy of recurrences of generalized forms of lymphogranulomatosis].
Vinokurova NA; Danova LA; Kondrat'ev VB; Gershanovich ML
Vopr Onkol; 1983; 29(7):46-50. PubMed ID: 6880132
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of Hodgkin's disease.
McElwain TJ
Br J Haematol; 1971 Sep; 21(3):362. PubMed ID: 5569541
[No Abstract] [Full Text] [Related]
15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy of advanced Hodgkin's disease.
Gray JL; Robinson WA
Rocky Mt Med J; 1973 Oct; 70(10):33-7. PubMed ID: 4748111
[No Abstract] [Full Text] [Related]
17. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
18. [Effectiveness of radio- and chemoradiotherapy of stage I-II Hodgkin's disease in children].
Tsyplenkov VG; Al'bitskaia IV
Med Radiol (Mosk); 1987 May; 32(5):21-3. PubMed ID: 3586918
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease in childhood: therapy results in Argentina.
Sackmann-Muriel F; Bonesana AC; Pavlovsky S; Papendieck C; Morgenfeld M; Penchansky L; Schwartz L; Kvicala R; Sica M; Ojeda F
Am J Pediatr Hematol Oncol; 1981; 3(3):247-54. PubMed ID: 7025683
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Koza I; Bohunický L; Mociková K; Gyárfás J; Svancárová L; Mardiak J; Spánik S; Fuchsberger P; Thalmeinerová Z; Sufliarsky J
Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
